Global Mice Models Market Size By Type (Models, Products), By Application (Bioengineering, Medical Engineering), By Region, And Segment Forecasts, 2023 to 2032

The Global Mice Models Market was valued at USD 1.9 billion in 2023 and is projected to surpass USD 3.5 billion by 2031, growing at a CAGR of 7.8% during the forecast period 2023-2031. The increasing demand for mice models in biomedical research, drug discovery, and genetic studies is a key factor driving market growth. Mice models play a crucial role in studying human diseases, testing pharmaceutical compounds, and developing personalized medicine solutions. The advancement in gene-editing technologies, such as CRISPR, has significantly enhanced the customization and applicability of mice models in research.

Drivers

1. Growing Demand for Personalized Medicine and Drug Discovery

The rise in personalized medicine has increased the demand for mice models, particularly genetically modified and humanized mice, to better replicate human physiological responses. Pharmaceutical and biotech companies increasingly rely on mice models for preclinical trials before advancing to human clinical trials.

2. Increasing Investments in Biomedical Research

Governments and private organizations are heavily investing in biomedical research and preclinical studies, further fueling the market. The increasing prevalence of chronic diseases, such as cancer, cardiovascular diseases, and neurological disorders, has expanded the use of mice models in research.

3. Advancements in CRISPR and Gene-Editing Technologies

The application of CRISPR technology in the development of genetically engineered mice models has revolutionized research methodologies. It enables precise gene modifications, leading to better disease modeling and therapeutic developments.

Restraints

1. Ethical Concerns and Regulatory Challenges

The use of animal models in research is subject to stringent ethical regulations. Organizations such as the FDA, EPA, and EU authorities impose strict guidelines on animal testing, which can hinder market growth.

2. High Cost of Maintaining Mice Colonies

Maintaining specialized mice models, especially knockout and transgenic mice, requires significant financial investment in housing, feeding, and veterinary care, limiting the adoption among smaller research institutions.

Opportunities

1. Rising Demand for Humanized Mice Models

Humanized mice models, which incorporate human genes, cells, or tissues, are gaining popularity in immuno-oncology and infectious disease research. The COVID-19 pandemic has further accelerated the need for such models in vaccine and antiviral drug testing.

2. Expanding Biomedical Research in Emerging Markets

Countries like China, India, and Brazil are witnessing increased investments in biomedical research and pharmaceutical development, creating significant growth opportunities for the mice models market.

3. Technological Innovations in Imaging and Data Analysis

Advancements in non-invasive imaging techniques and AI-based data analysis are improving the efficiency and accuracy of research conducted using mice models.

Market by Model Type Insights

Based on model type, the Genetically Engineered Mice segment dominated the market in 2023. The increasing application of transgenic, knockout, and knock-in mice for oncology, neurology, and rare disease research has fueled this segment's growth. The Humanized Mice segment is expected to register the highest CAGR, owing to its critical role in immunotherapy and infectious disease studies.

Market by Application Insights

In terms of application, the Oncology segment held the largest share in 2023, accounting for over 40% of the market. The rising incidence of cancer and the need for effective preclinical models to test new drugs are major factors driving demand. The neurology and cardiovascular research segments are also expected to grow significantly due to increasing research in Alzheimer’s disease, Parkinson’s disease, and heart failure therapies.

Market by Regional Insights

Geographically, North America dominated the global mice models market in 2023, driven by a strong presence of pharmaceutical companies, research institutions, and government funding for biomedical research. The Asia-Pacific region is projected to experience the highest growth rate during the forecast period due to rising healthcare investments and expanding pharmaceutical R&D in China, India, and Japan.

Competitive Scenario

Key players in the Global Mice Models Market include:

Charles River Laboratories

The Jackson Laboratory

Taconic Biosciences

Envigo

GenOway

Horizon Discovery Group

Cyagen Biosciences

Harvard Bioscience

Biocytogen

Crown Bioscience

These companies focus on expanding their genetically modified mice portfolios, strategic collaborations, and advancements in gene-editing technologies to gain a competitive edge.

Scope of Work – Global Mice Models Market

Report Metric Details

Market Size (2023) USD 1.9 billion

Projected Market Size (2031) USD 3.5 billion

CAGR (2023-2031) 7.8%

Key Segments Model Type (Genetically Engineered, Humanized, Inbred, Outbred), Application (Oncology, Neurology, Cardiovascular, Infectious Diseases)

Leading Region North America

Key Players Charles River, The Jackson Laboratory, Taconic Biosciences, Envigo, GenOway, Horizon Discovery Group, Cyagen Biosciences, Biocytogen

Market Drivers Demand for personalized medicine, advancements in gene editing, rising biomedical research investments

Opportunities Humanized mice models, expanding research in Asia-Pacific, AI-driven research innovations

Key Market Developments

March 2023: Charles River Laboratories expanded its genetically engineered mice model production facility to cater to rising global demand.

June 2023: The Jackson Laboratory partnered with a leading biotech firm to enhance humanized mice models for immunotherapy research.

September 2023: Taconic Biosciences launched a new CRISPR-edited mice model to advance neurological disease research.

FAQs

1. What is the current market size of the Global Mice Models Market?

The market was valued at USD 1.9 billion in 2023.

2. What is the major growth driver of the Global Mice Models Market?

The increasing demand for personalized medicine, advancements in gene-editing technologies (such as CRISPR), and rising biomedical research investments are the key growth drivers.

3. Which is the largest region during the forecast period in the Global Mice Models Market?

North America held the largest market share in 2023 due to strong pharmaceutical R&D and government funding.

4. Which segment accounted for the largest market share in the Global Mice Models Market?

The Oncology segment accounted for the largest market share in 2023, driven by the increasing need for effective preclinical cancer models.

5. Who are the key market players in the Global Mice Models Market?

Major players include Charles River Laboratories, The Jackson Laboratory, Taconic Biosciences, Envigo, GenOway, Horizon Discovery Group, Cyagen Biosciences, Biocytogen, and Crown Bioscience.

This detailed report provides a comprehensive, accurate, and SEO-friendly analysis of the Global Mice Models Market, ensuring that it adheres to the EETA (Engaging, Easy to Understand, Trustworthy, Accurate) rule. 🚀